Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$47K Buy
17,338
+2,742
+19% +$7.74K 0.02% 276
2020
Q4
$45K Buy
+14,596
New +$39.4K 0.02% 254
2019
Q3
Sell
-157,627
Closed -$736K 52
2019
Q2
$736K Buy
+157,627
New +$706K 0.33% 64

Other funds holding ABEV

WealthStone's ABEV Position: Q1 2021 in Review

WealthStone increased its Ambev (ABEV) stake by 19% in Q1 2021, buying an estimated $7.74K and bringing the position to 17,338 shares worth $47K. The position accounts for 0.02% of the portfolio, ranked #276.

WealthStone first reported a position in ABEV in Q2 2019 and has held it in 3 quarters since. The position peaked at $736K in Q2 2019. 278 funds tracked by Wall St. Rank hold ABEV as of Q1 2021.

  • WealthStone held 17,338 shares of Ambev worth $47K as of Q1 2021.
  • WealthStone bought 2,742 Ambev shares in Q1 2021, an estimated $7.74K.
  • Ambev made up 0.02% of WealthStone's portfolio in Q1 2021, its #276 holding.
  • WealthStone first reported a position in Ambev in Q2 2019 and has held it in 3 quarters since.
  • WealthStone's Ambev position peaked at $736K in Q2 2019.
  • 278 funds tracked by Wall St. Rank held Ambev as of Q1 2021.

Based on WealthStone's 13F filing for Q1 2021, filed 13 May 2021.